The stressful condition as a nutritionally dependent adaptive dichotomy

Nutrition

Volumn 15, Issue 4, 1999, Pages 305-320

  Ingenbleek, Yves ^a   Bernstein, Larry ^b  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b Dept of Pathol and Lab Medicine ^*  (United States)

Author keywords

Acute phase response; Growth factors; Nutritional status; Retinoid metabolism; Steroidogenesis; Stress; Thyroid function

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALKALINE PHOSPHATASE; CATECHOLAMINE; CORTICOTROPIN; CYTOKINE; GLUCAGON; GROWTH HORMONE; HAPTOGLOBIN; HYDROCORTISONE; INSULIN; LIOTHYRONINE; LIPID; MANNOSYLTRANSFERASE; MESSENGER RNA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (ATP); PREALBUMIN; PYRUVATE DEHYDROGENASE; RECEPTOR; RETINOIC ACID; RETINOL; RETINOL BINDING PROTEIN; SERINE PROTEINASE INHIBITOR; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; THYROTROPIN; THYROXINE; THYROXINE BINDING PROTEIN; TRANSCORTIN; TRANSCRIPTION FACTOR; UNINDEXED DRUG;

ACUTE PHASE RESPONSE; ADAPTATION; ADRENAL GLAND; BINDING SITE; FEEDBACK SYSTEM; HUMAN; METABOLISM; NONHUMAN; NUTRITION; NUTRITIONAL STATUS; PANCREAS; PRIORITY JOURNAL; REVIEW; STEROIDOGENESIS; STRESS; THYROID FUNCTION; THYROID GLAND;

ADAPTATION, PHYSIOLOGICAL; ENDOCRINE GLANDS; HUMANS; HYDROCORTISONE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; NUTRITIONAL STATUS; PREALBUMIN; RETINOIDS; RETINOL-BINDING PROTEINS; STRESS; THYROID GLAND; TRANSCORTIN;

EID: 0032902174     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(99)00009-X     Document Type: Review

References (272)

1. Beisel W.R. Metabolic response to infection. Annu Rev Med. 26:1975;9.
2. Powanda M.C. Changes in body balances of nitrogen and other key nutrients description and underlying mechanisms . Am J Clin Nutr. 30:1977;1254.
3. Wilmore D.W. Alterations in protein, carbohydrate, and fat metabolism in injured and septic patients. J Am Coll Nutr. 2:1983;3.
4. Frayn K.N. Hormonal control of metabolism in trauma and sepsis. Clin Endocrinol. 24:1986;577.
5. Stoner H.B. Metabolism after trauma and in sepsis. Circ Shock. 19:1986;75.
6. Barton R.N. The neuroendocrinology of physical injury. Grossman A. Baillière's clinical endocrinology and metabolism. 1987;355 Baillière Tindall, London.
7. Watters J.M., Bessey P.Q., Dinarello C.A. Both inflammatory and endocrine mediators stimulate host responses to sepsis. Arch Surg. 121:1986;179.
8. Beutler B., Cerami A. Cachectin (tumor necrosis factor) a macrophage hormone governing cellular metabolism and inflammatory response . Endocr Rev. 9:1988;57.
9. Imura H., Fukata J., Mori T. Cytokines and endocrine function an interaction between the immune and neuroendocrine systems . Clin Endocrinol. 35:1991;107.
10. Kennedy R.L., Jones T.H. Cytokines in endocrinology their roles in health and in disease . J Endocrinol. 129:1991;167.
11. Robbins J., Rall J.E. The interaction of thyroid hormones and protein in biological fluids. Recent Progr Horm Res. 13:1957;161.
12. Mendel C.M. The free hormone hypothesis a physiologically based mathematical model . Endocr Rev. 10:1989;232.
13. Evans R.M. The steroid and thyroid receptor superfamily. Science. 240:1988;889.
14. Nunez E.A. The erb-A family receptors for thyroid hormones, steroids, vitamin D and retinoic acid characteristics and modulation . Curr Opin Cell Biol. 1:1989;177.
15. Green S., Chambon P. Nuclear receptors enhance our understanding of transcription regulation. Trends Genet. 4:1988;309.
16. Miner J.N., Yamamoto K.R. Regulatory crosstalk at composite response elements. Trends Biochem Sci. 16:1991;423.
17. Ingenbleek Y., Young V. Transthyretin (prealbumin) in health and disease nutritional implications . Annu Rev Nutr. 14:1994;495.
18. Sapolsky R., Rivier C., Yamamoto G., Plotsky P., Vale W. Interleukin 1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science. 238:1987;522.
19. Naitoh Y., Fukata J., Tominaga T., et al. Interleukin-6 stimulates the secretion of adrenocorticotrophic hormone in conscious, freely-moving rats. Biochem Biophys Res Commun. 155:1988;1459.
20. Bernardini R., Kamilaris T.C., Calogero A.E., et al. Interaction between tumor necrosis factor, hypothalamic corticotrophin-releasing hormone and adrenocorticotrophin secretion in the rat. Endocrinology. 126:1990;2876.
21. Tominaga T., Fukata J., Naito Y., et al. Prostaglandin-dependent in vitro stimulation of adrenocortical steroidogenesis by interleukins. Endocrinology. 128:1991;526.
22. Malarkey W.B., Zvara B.J. Interleukin-1β and other cytokines stimulate adrenocorticotropin release from cultured pituitary cells of patients with Cushing's disease. J Clin Endocrinol Metab. 69:1989;196.
23. Dennhardt R., Gramm H.J., Meihold K., Voigt K. Patterns of endocrine secretion during sepsis. Progr Clin Biol Res. 308:1989;751.
24. Sibbald W.J., Short A., Cohen M.P., Wilson R.F. Variations in adrenocortical responsiveness during severe bacterial infections. Ann Surg. 186:1977;29.
25. Parker L.N., Levin E.R., Lifrak E.T. Evidence for adrenocortical adaptation to severe illness. J Clin Endocrinol Metab. 60:1985;947.
26. Nishijima M.K., Breslow M.J., Raff H., Traystman R.J. Regional adrenal blood flow during hypoxia in anesthetized, ventilated dogs. Am J Physiol. 256:1989;H94.
27. Chernow B., Alexander H.R., Smallridge R.C., et al. Hormonal responses to graded surgical stress. Arch Intern Med. 147:1987;1273.
28. Schein R.M.H., Sprung C.L., Marcial E., Napolitano L., Chernow B. Plasma cortisol levels in patients with septic shock. Crit Care Med. 18:1990;259.
29. Wise L., Margraf H.W., Ballinger W.F. Adrenal cortical function in severe burns. Arch Surg. 105:1972;213.
30. Alberti K.G.M.M., Batstone G.F., Foster K.J., Johnston D.G. Relative role of various hormones in mediating the metabolic response to injury. JPEN. 4:1980;141.
31. Vaughan G.M., Becker R.A., Allen J.P., et al. Cortisol and corticotrophin in burned patients. J Trauma. 22:1982;263.
32. Shamoon H., Hendler R., Sherwin R.S. Altered responsiveness to cortisol, epinephrine, and glucagon in insulin-infused juvenile-onset diabetics. A mechanism for diabetic instability. Diabetes. 29:1980;284.
33. Hall-Angerås M., Angerås U., Zamir O., Hasselgren P.O., Fisher J.E. Interaction between corticosterone and tumor necrosis factor stimulates protein breakdown in rat skeletal muscle, similar to sepsis. Surgery. 108:1990;460.
34. Cuthbertson D.P. Post-shock metabolic response. Lancet. i:1942;433.
35. Wilmore D.W., Lindsey C.A., Moyland J.A., et al. Hyperglycagonaemia after burns. Lancet. i:1974;73.
36. Rocha D.M., Santeusiano F., Faloona G.R., Unger R.H. Abnormal pancreatic alpha-cell function in bacterial infections. N Engl J Med. 288:1973;700.
37. Unger RH, Orci L. Glucagon and the A cell: physiology and pathophysiology. N Engl J Med 1981;304:1518, 1575.
38. Newsholme E.A., Leech A.R. Control of gluconeogenesis and glycogenolysis. Newsholme E.A., Leech A.R. Biochemistry for the medical sciences. 1990;450 John Wiley & Sons, Chichester.
39. Souba W.W., Herskowitz K., Salloum R.M., Chen M.K., Austgen T.R. Gut glutamine metabolism. JPEN. 14:1990;S45.
40. Warren R.S., Donner D.B., Starnes H.F. Jr, Brennan M. Modulation of endogenous hormone action by recombinant human tumor necrosis factor. Proc Natl Acad Sci USA. 84:1987;8619.
41. Heinrich P.C., Castell J.V., Andus T. Interleukin-6 and the acute phase response. Biochem J. 265:1990;621.
42. Wolfe R.R., Durkot M.J., Allsop J.R., Burke J.F. Glucose metabolism in severely burned patients. Metabolism. 28:1979;1031.
43. Giddings A.E.B., O'Connor K.J., Rowlands B.J., Mangnall D., Clark R.G. The relationship of plasma glucagon to the hyperglycaemia and hyperinsulinaemia of surgical operation. Br J Surg. 63:1976;612.
44. Porte D. Jr, Robertson R.P. Control of insulin secretion by catecholamines, stress, and the sympathetic nervous system. Fed Proc. 32:1973;1792.
45. Rosner M.J., Newsome H.H., Becker D.P. Mechanical brain injury the sympathoadrenal response . J Neurosurg. 61:1984;6.
46. Woolf P.D., Hamill R.W., Lee L.A., Cox C., McDonald J.V. The predictive value of catecholamines in assessing outcome in traumatic brain injury. J Neurosurg. 66:1987;875.
47. Sherwin R.S. Effect of epinephrine on fuel metabolism in man role in the response to stress . Kleinberger G., Deutsch E. New aspects of clinical nutrition. 1983;283 Karger, Basel.
48. Miller R.E. Pancreatic neuroendocrinology peripheral neural mechanisms in the regulation of the islets of Langerhans . Endocr Rev. 2:1981;471.
49. Clutter W.E., Bier D.M., Shah S.D., Cryer P.E. Epinephrine plasma metabolic clearance rates and physiological thresholds for metabolic and hemodynamic actions in man. J Clin Invest. 66:1980;94.
50. Deibert D.C., DeFronzo R.A. Epinephrine-induced insulin resistance in man. J Clin Invest. 65:1980;717.
51. Hotamisligil G.S., Budavari A., Murray D., Spiegelman B.M. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-α J Clin Invest. 94:1994;1543.
52. Häring H., Kirsch D., Obermaier B., Ermel B., Machicao F. Decreased tyrosine kinase activity of insulin receptor isolated from rat adipocytes rendered insulin-resistant by catecholamine treatment in vitro. Biochem J. 234:1986;59.
53. Caron M., Reynet C., Wicek D., et al. Insulin receptor mutation at tyrosines 1162 and 1163 alters both receptor serine phosphorylation and desensitization. Metabolism. 43:1994;757.
54. Giustina A., Wehrenberg W.B. Influence of thyroid hormones on the regulation of growth hormone secretion. Eur J Endocrinol. 131:1995;646.
55. Delitala G., Tomasi P., Virdis R. Prolactin, growth hormone and thyrotropin-thyroid hormone secretion during stress states in man. Grossman A. Baillière's clinical endocrinology and metabolism. 1987;391 Baillière Tindall, London.
56. Møller N., Schmitz O., Pørksen N., Møller J., Jørgensen J.O. Dose-response studies on the metabolic effects of a growth hormone pulse in humans. Metabolism. 41:1991;172.
57. Harvey S., Scanes C.G., Daughaday W.H. Growth hormone basic, clinical and applied aspects . 1995;CRC Press, Boca Raton.
58. Moller D.E. Insulin resistance. 1993;John Wiley & Sons.
59. Dietz J., Schwartz J. Growth hormone alters lipolysis and hormone-sensitive lipase activity in 3T3-F442A adipocytes. Metabolism. 40:1991;800.
60. Rinderknecht E., Humbel R.E. The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem. 253:1978;2769.
61. Copeland K.C., Underwood L.E., Van Wyk J.J. Induction of immunoreactive somatomedin C in human serum by growth hormone dose-response relationships and effect on chromatographic profiles . J Clin Endocrinol Metab. 50:1980;690.
62. Berelowitz M., Szabo M., Frohman L.A., et al. Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science. 212:1981;1279.
63. Shimasaki S., Ling N. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Prog Growth Factor Res. 3:1992;243.
64. Martin J.L., Baxter J.C. Insulin-like growth factor binding protein-3 biochemistry and physiology . Growth Regulat. 2:1992;88.
65. Jones J.I., Clemmons D.R. Insulin-like growth factors and their binding proteins Biological actions . Endocr Rev. 16:1995;3.
66. 125I] IGF-1. J Clin Endocrinol Metab. 80:1995;1318.
67. Guler H.P., Zapf J., Schmid C., Froesch E.R. Insulin-like growth factors I and II in healthy man. Estimations of half-lifes and production rates. Acta Endocrinol. 121:1989;753.
68. Frystyk J., Skjaerbaek C., Dinesen B., Ørskov H. Free insulin-like growth factors (IGF-1 and IGF-1I) in human serum. FEBS Lett. 348:1994;185.
69. Malatinsky J., Vigas M., Jurcovicova J., et al. The patterns of endocrine response to surgical stress during different types of anesthesia and surgery in man. Acta Anaesthesiol Belg. 37:1986;23.
70. Välimäki M., Liewendahl K., Karonen S.L., Helenius T., Suikkari A.M. Concentrations of somatomedin-C and triiodothyronine in patients with thyroid dysfunction and nonthyroidal illnesses. J Endocrinol Invest. 13:1990;155.
71. Ross R., Miell J., Freeman E., et al. Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-1. Clin Endocrinol. 35:1991;47.
72. Ingenbleek Y. Thyroid function in nonthyroid illnesses. De Visscher M. The thyroid gland. 1980;499 Raven Press, New York.
73. Wartofsky L., Burman K.D. Alterations in thyroid function in patients with systemic illness the euthyroid sick syndrome . Endocr Rev. 3:1982;164.
74. Talwar K.K., Sawhney R.C., Rastogi G.K. Serum levels of thyrotropin, thyroid hormones and their response to thyrotropin releasing hormone in infective febrile illnesses. J Clin Endocrinol Metab. 44:1977;398.
75. Prescott R.W., Yeo P.P., Watson M.J., et al. Total and free thyroid hormone concentrations after elective surgery. J Clin Pathol. 32:1979;321.
76. Oppenheimer J.H., Schwartz H.L., Mariash C.N., et al. Advances in our understanding of thyroid hormone action at cellular level. Endocr Rev. 8:1987;288.
77. Reichlin S., Utiger R.D. Regulation of the pituitary-thyroid axis in man; relationship of TSH concentration to concentration of free and total thyroxine in plasma. J Clin Endocrinol. 27:1967;251.
78. Dubuis J.M., Dayer J.M., Siegrist-Kaiser C.A., Burger A.G. Human recombinant interleukin-1β decreases plasma thyroid hormone and thyroid stimulating hormone levels in rats. Endocrinology. 123:1988;2175.
79. Bartalena L., Brogioni S., Grasso L., Velluzzi F., Martino E. Relationship of the increased serum interleukin-6 concentration to changes of thyroid function in nonthyroidal illness. J Endocrinol Invest. 17:1994;269.
80. Tang K.T., Braverman L.E., DeVito W.J. Tumor necrosis factor-α and interferon-γ modulate gene expression of type I 5'-deiodinase, thyroid peroxidase and thyroglobulin in FRTL-5 rat thyroid cells. J Clin Endocrinol Metab. 136:1995;881.
81. Docter R., Krenning E.P., de Jong M., Hennemann G. The sick euthyroid syndrome changes in thyroid hormone serum parameters and hormone metabolism . Clin Endocrinol. 39:1993;499.
82. Vignati L., Finley R.J., Hagg S., Aoki T.T. Protein conservation during prolonged fast a function of triiodothyronine levels . Trans Assoc Am Physicians. 91:1978;169.
83. Utiger R.D. Decreased extrathyroidal triiodothyronine production in nonthyroidal illness benefit or harm? Am J Med. 69:1980;807.
84. Danforth E. Jr, Burger A.G. The role of thyroid hormones in the control of energy expenditure. Clin Endocrinol Metab. 13:1984;581.
85. Kapstein E.M., Weiner J.M., Robinson W.J., Wheeler W.S., Nicoloff J.T. Relationship of altered thyroid indices to survival in non thyroidal illness. Clin Endocrinol. 16:1982;565.
86. Chioléro R., Lemarchand-Béraud T., Schutz Y., et al. Thyroid function in severely traumatized patients with and without head injury. Acta Endocrinol. 117:1988;80.
87. Askanazi J., Carpentier Y.A., Elwyn D.H., et al. Influence of total parenteral nutrition on fuel utilization in injury and sepsis. Ann Surg. 191:1980;40.
88. Wilmore D.W., Aulick L.H., Mason A.D. Jr, Pruitt B.A. Jr. Influence of the burn wound on local and systemic responses to injury. Ann Surg. 186:1977;444.
89. Ryan N.T., Blackburn G.L., Clowes G.H.A. Jr. Differential tissue sensitivity to elevated endogenous insulin levels during experimental peritonitis in rats. Metabolism. 23:1974;1081.
90. Patel M.S., Roche T.E. Molecular biology and biochemistry of pyruvate dehydrogenase complexes. FASEB J. 4:1990;3224.
91. Brand K.A., Hermfisse U. Aerobic glycolysis by proliferating cells a protective strategy against reactive oxygen species . FASEB J. 11:1997;388.
92. Hammond G.L., Smith C.L., Goping I.S., et al. Primary structure of human corticosteroid binding globulin, deduced from hepatic and pulmonary cDNAs, exhibits homology with serine protease inhibitors. Proc Natl Acad Sci USA. 84:1987;5153.
93. Siiteri P.K., Murai J.T., Hammond G.L., et al. The serum transport of steroid hormones. Recent Prog Horm Res. 38:1982;457.
94. Anderson K.E., Roser W., Khan M.S., et al. Diet-hormone interactions protein/carbohydrate ratio alters reciprocally the plasma levels of testosterone and cortisol and their respective binding globulins in man . Life Sci. 40:1987;1761.
95. Zouaghi H., Savu L., Delorme J., Kleinknecht D., Nunez E.A. Loss of serum transcortin in human shock associated with severe infection by candida albicans. Acta Endocrinol. 102:1983;277.
96. Pugeat M., Bonneton A., Perrot D., et al. Decreased immunoreactivity and binding activity of corticosteroid-binding globulin in serum in septic shock. Clin Chem. 35:1989;1675.
97. Bartalena L., Hammond G.L., Farsetti A., Flink I.L., Robbins J. Interleukin-6 inhibits corticosteroid-binding globulin synthesis by human hepatoblastoma-derived (Hep G2) cells. Endocrinology. 133:1993;291.
98. Hryb D.J., Khan M.S., Romas N.A., Rosner W. Specific binding of human corticosteroid-binding globulin to cell membranes. Proc Natl Acad Sci USA. 83:1986;3253.
99. Hammond G.L., Smith C.L., Paterson N.A.M., Sibbald W.J. A role for corticosteroid-binding globulin in delivery of cortisol to activated neutrophils. J Clin Endocrinol Metab. 71:1990;34.
100. Travis J., Salvesen G.S. Human plasma proteinase inhibitors. Annu Rev Biochem. 52:1983;655.
101. Schlechte J.A., Hamilton D. The effects of glucocorticoids on corticosteroid-binding globulin. Clin Endocrinol. 27:1987;197.
102. Bright G.M. Corticosteroid-binding globulin influences kinetic parameters of plasma cortisol transport and clearance. J Clin Endocrinol Metab. 80:1995;770.
103. Olsson T. Urinary free cortisol excretion shortly after ischaemic stroke. J Intern Med. 228:1990;177.
104. Mohler J.L., Michael K.A., Freedman A.M., Griffen W.O. Jr, McRoberts J.W. The serum and urinary cortisol response to operative trauma. Surg Gynecol Obstet. 161:1985;445.
105. Barton R.N., Weijers J.W.M., Horan M.A. Increased rates of cortisol excretion in elderly women 2 weeks after proximal femur fracture. Eur J Clin Invest. 23:1993;171.
106. Mendel C.M., Kuhn R.W., Weisiger R.A., et al. Uptake of cortisol by the perfused rat liver validity of the free hormone hypothesis applied to cortisol . Endocrinology. 124:1989;468.
107. Meltzer M.S., Nacy C.A. Cell-cell interactions during inflammation the role of macrophage . Cerra F.B., Shoemaker W.D. Critical care state of the art. 1987;119 Society of Critical Care Medicine, Fullerton CA.
108. Waage A., Bakke O. Glucocorticoids suppress the production of tumour necrosis factor by lipopolysaccharide-stimulated human monocytes. Immunology. 63:1988;299.
109. Barber A.E., Coyle S.M., Marano M.A., et al. Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol. 150:1993;1999.
110. Tsujimoto M., Okamura N., Adachi H. Dexamethasone inhibits the cytotoxic activity of tumor necrosis factor. Biochem Biophys Res Commun. 153:1988;109.
111. Geller D.A., Nussler A.K., Di Silvio M., et al. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci USA. 90:1993;522.
112. van der Poll T., Lowry S.F. Tumor necrosis factor in sepsis mediator of multiple organ failure or essential part of host defense? Shock. 3:1995;1.
113. Hynes N.E., van Ooyen A.J., Kennedy N., et al. Subfragments of the large terminal repeatedly cause glucocorticoid-responsive expression of mouse mammary tumor virus and of an adjacent gene. Proc Natl Acad Sci USA. 80:1983;3637.
114. Rousseau G.G., Amar-Costesec A., Verhaegen M., Granner D.K. Glucocorticoid hormones increase the activity of plasma membrane alkaline phosphodiesterase I in rat hepatoma cells. Proc Natl Acad Sci USA. 77:1980;1005.
115. Olson P.S., Thompson E.B., Granner D.K. Regulation of hepatoma tissue culture cell aminotransferase messenger ribonucleic acid by dexamethasone. Biochemistry. 19:1980;1705.
116. Danesch U., Hashimoto S., Renkawitz R., Schütz G. Transcriptional regulation of the tryptophan oxygenase gene in rat liver by glucocorticoids. J Biol Chem. 258:1983;4750.
117. Cox R.P., Elson N.A., Tu S.H., Griffin M.J. Hormonal induction of alkaline phosphatase activity by an increase in catalytic efficiency of the enzyme. J Mol Biol. 58:1971;197.
118. Pogson G.I., Smith S.A. The activity of phosphoenolpyruvate carboxykinase in rat tissues. Assay techniques and effects of dietary and hormonal changes. Biochem J. 152:1975;401.
119. Sarkar M., Mookerjea S. Effect of dexamethasone on mannolipid synthesis by hepatocytes prepared from control and inflamed rats. Biochem J. 219:1984;429.
120. Baumann H., Richards C., Gauldie J. Interaction among hepatocyte-stimulating factors, interleukin-1, and glucocorticoids for regulation of acute phase plasma proteins in human hepatoma (Hep G2) cells. J Immunol. 139:1987;4122.
121. Gauldie J., Richards C., Harnish D., Lansdorp P., Baumann H. Interferon β2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA. 84:1987;7251.
122. Vannice J.L., Ringold G.M., McLean J.W., Taylor J.M. Induction of the acute phase reactant, α1-acid glycoprotein, by glucocorticoids in rat hepatoma cells. DNA. 2:1983;205.
123. Castell J.V., Gómez-Lechón M.J., David M., et al. Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett. 232:1988;347.
124. Rose-John S., Schooltink H., Lenz D., et al. Studies on the structure and regulation of the human hepatic interleukin-6 receptor. Eur J Biochem. 190:1990;79.
125. Depraetere S., Willems J., Joniau M. Stimulation of CRP secretion in Hep G2 cells cooperative effect of dexamethasone and interleukin 6 . Agents Actions. 34:1991;369.
126. Rousseau G.G. Control of gene expression by glucocorticoid hormones. Biochem J. 224:1984;1.
127. Robbins J., Rall J.E. The iodine-containing hormones. Gray C.H., Bacharach A.L. Hormones in blood. 1979;576 Academic Press, New York.
128. Robbins J., Bartalena L. Plasma transport of thyroid hormones. Hennemann G. Thyroid hormone metabolism. 1986;3 Marcel Dekker, New York.
129. Oppenheimer J.H., Schwartz H.L., Surks M.I. Determination of common parameters of iodothyronine metabolism and distribution in man by noncompartmental analysis. J Clin Endocrinol Metab. 41:1975;319.
130. Irvine C.H.G. Four compartment model of thyroxine metabolism. Harland W.A., Orr J.S. Thyroid hormone metabolism. 1975;163 Academic Press, London.
131. Vahlquist A., Rask L., Peterson P.A., Berg T. The concentrations of retinol-binding protein, prealbumin and transferrin in the sera of newly delivered mothers and children of various ages. Scand J Clin Lab Invest. 35:1975;569.
132. Ingenbleek Y., Van den Schrieck H.G., De Nayer P., De Visscher M. The role of retinol-binding protein in protein-calorie malnutrition. Metabolism. 24:1975;633.
133. Kasper H., Brodersen M., Schedel R. Concentration of vitamin A, retinol-binding protein and prealbumin in serum in response to stress. Acta Hepato-Gastroenterol. 22:1975;403.
134. Ramsden D.B., Prince H.P., Burr W.A., et al. The inter-relationship of thyroid hormones, vitamin A and their binding proteins following acute stress. Clin Endocrinol. 8:1978;109.
135. Gofferje H., Maintz E. Das verhalten von präalbumin, retinol-bindendem protein, transferrin und haptoglobin in der postoperativen und posttraumatischen phase. Infusiontherapie. 5:1978;268.
136. Isshiki H., Akira S., Sugita T., et al. Reciprocal expression of NF-Il6 and C/EBP in hepatocytes possible involvement of NF-Il6 in acute phase protein gene expression . New Biologist. 3:1991;63.
137. Akira S, Isshiki H, Nakajima T, et al. Regulation of expression of the interleukin 6 gene: structure and function of the transcription factor NF-Il6. In: Bock GR, Widdows K, eds. Polyfunctional cytokines: IL-6 and LiF. Ciba Foundation Symposium, Chichester, Wiley, UK, 1992:47.
138. Shenkin A. Cytokine changes in the postoperative period. Proc Nutr Soc. 53:1994;159.
139. Mendel C.M., Cavalieri R.R., Weisiger R.A. Uptake of thyroxine by the perfused rat liver implications for the free hormone hypothesis . Am J Physiol. 255:1988;E110.
140. Seelig S., Liaw C., Towle H.C., Oppenheimer J.H. Thyroid hormone attenuates and augments hepatic gene expression at a pretranslational level. Proc Natl Acad Sci USA. 78:1981;4733.
141. Guernsey D.L., Edelman I.S. Regulation of thermogenesis by thyroid hormones. Oppenheimer J.H., Samuels H. Molecular basis of thyroid hormone action. 1983;293 Academic Press, New York.
142. Pain B., Melet F., Jurdic P., Samarut J. The carbonic anhydrase II gene, a gene regulated by thyroid hormone and erythropoietin is repressed by the v-erbA oncogene in erythrocytic cells. New Biologist. 2:1990;284.
143. Van Hardeveld C. Effects of thyroid hormone on oxygen consumption, heat production, and energy economy. Hennemann G. Thyroid hormone metabolism. 1986;574 Marcel Dekker, New York.
144. Seitz H.J., Müller M.J., Soboll S. Rapid thyroid-hormone effect on mitochondrial and cytosolic ATP/ADP ratios in the intact liver cell. Biochem J. 227:1985;149.
145. Müller M.J., Seitz H.J. Thyroid hormone action on intermediary metabolism. Part I. Respiration, thermogenesis and carbohydrate metabolism. Klin Wochenschr. 62:1984;11.
146. Mariash C.N., Oppenheimer J.H. Thyroid hormone-carbohydrate interaction. Oppenheimer J.H., Samuels H.H. Molecular basis of thyroid hormone action. 1983;265 Academic Press, New York.
147. Dozin B., Magnuson M.A., Nikodem V.M. Thyroid hormone regulation of malic enzyme synthesis. Dual tissue-specific control. J Biol Chem. 261:1986;10290.
148. Müller M.J., Seitz H.J. Thyroid hormone action on intermediary metabolism. Part II. Lipid metabolism in hypo- and hyperthyroidism. Klin Wochensch. 62:1984;49.
149. Stiles G.L., Caron M.G., Lefkowitz R.J. β-adrenergic receptors biochemical mechanisms of physiological regulation . Physiol Rev. 64:1984;661.
150. Ness G.C., Pendleton L.C., Li Y.C., Chiang J.Y. Effect of thyroid hormone on hepatic cholesterol 7 alpha hydroxylase, LDL receptor, HMG-CoA reductase, farnesyl pyrophosphate synthetase and apolipoprotein A-I mRNA in hypophysectomized rats. Biochem Biophys Res Commun. 172:1990;1150.
151. Scarpulla R.C., Kilar M.C., Scarpulla K.M. Coordinate induction of multiple cytochrome C mRNAs in response to thyroid hormone. J Biol Chem. 261:1986;4660.
152. Berry M.J., Kates A.L., Larsen P.R. Thyroid hormone regulates type I deiodinase messenger RNA in rat liver. Mol Endocrinol. 4:1990;743.
153. Ikeda T., Fujiyama K., Hoshino T., et al. Stimulating effect of thyroid hormone on insulin-like growth factor I release and synthesis by perfused rat liver. Growth Regul. 1:1991;39.
154. Wion D., Barrand P., Dicou E., Scott J., Brachet P. Serum and thyroid hormones T3 and T4 regulate nerve growth factor mRNA levels in mouse L cells. FEBS Lett. 189:1985;37.
155. Mukku V.R. Regulation of epidermal growth factor receptor levels by thyroid hormones. J Biol Chem. 259:1984;6453.
156. Kobayashi M., Horiuchi R., Hachisu T., Takikawa H. Dualistic effects of thyroid hormone on a human hepatoma cell line inhibition of thyroxine-binding globulin synthesis and stimulation of α1-acid glycoprotein synthesis . Endocrinology. 123:1988;631.
157. Graninger W., Pirich K., Derfler K., Waldhäusl W. Plasma fibronectin and thyroid function. J Clin Pathol. 38:1985;64.
158. Faber J., Perrild H., Johansen J.S. Bone Gla protein and sex hormone-binding globulin in nontoxic goiter parameters for metabolic status at the tissue level . J Clin Endocrinol Metab. 70:1990;49.
159. Izumo S., Nadal-Ginard B., Mahdavi V. All members of the MHC multigene family respond to thyroid hormone in a highly tissue-specific manner. Science. 231:1986;597.
160. Takamatsu J., Majima M., Miki K., Kuma K., Mozai T. Serum ferritin as a marker of thyroid hormone action on peripheral tissues. J Clin Endocrinol Metab. 61:1985;672.
161. Schroeder C., Gibson L., Zenke M., Beug H. Modulation of normal erythroid differentiation by the endogenous thyroid hormone and retinoid acid receptors a possible target for v-erb A oncogene action . Oncogene. 7:1992;217.
162. Woeber K.A., Doherty G.F., Ingbar S.H. Stimulation by phagocytosis of the deiodination of L-thyroxine in human leukocytes. Science. 176:1972;1039.
163. Burch W.M., Van Wyk J.J. Triiodothyronine stimulates cartilage growth and maturation by different mechanisms. Am J Physiol. 252:1987;E176.
164. Tomic M., Jiang C.K., Epstein H.S., et al. Nuclear receptors for retinoic acid and thyroid hormone regulate transcription of keratin genes. Cell Regul. 1:1990;965.
165. Gurr J.A., Kourides I.A. Thyroid hormone regulation of thyrotropin α- and β-subunit gene transcription. DNA. 4:1985;301.
166. Morin A., Louette J., Voz M.L., et al. Triiodothyronine inhibits transcription from the human growth hormone promoter. Mol Cell Endocrinol. 71:1990;261.
167. Barlow J.W., Crowe T.C., Cowen N.L., et al. Stimulation of sex hormone-binding globulin mRNA and attenuation of corticosteroid-binding globulin mRNA by triiodothyronine in human hepatoma cells. Eur J Endocrinol. 130:1994;166.
168. Flink I.L., Bailey T.J., Gustafson T.A., Markham B.E., Morkin E. Complete amino acid sequence of human thyroxine-binding globulin deduced from cloned DNA Close homology to the serine antiproteases . Proc Natl Acad Sci USA. 83:1986;7708.
169. Pemberton P.A., Stein P.E., Pepys M.B., Potter J.M., Carrell R.W. Hormone binding globulins undergo serpin conformational changes in inflammation. Nature. 336:1988;257.
170. Fujii T., Sato K., Ozawa M., et al. Effect of interleukin-1 (IL-1) on thyroid metabolism in mice stimulation by IL-1 of iodothyronine 5'-deiodinating activity (type I) in the liver . Endocrinology. 124:1989;167.
171. Davies P.H., Sheppard M.C., Franklyn J.A. Interleukin-6 regulates type I 5'-deiodinase in rat liver cells [Abstract]. Thyroid. 4:(suppl 1):1994;S32.
172. Ozawa M., Sato K., Han D.C., Kawakami M., Tsushima T., Shizume K. Effects of tumor necrosis factor-α/cachectin on thyroid hormone metabolism in man. Endocrinology. 123:1988;1461.
173. Silva J.E., Larsen P.R. Regulation of thyroid hormone expression at the prereceptor and receptor levels. Hennemann G. Thyroid hormone metabolism. 1986;441 Marcel Dekker, New York.
174. Blomhoff R., Green M.H., Green J.B., Berg T., Norum K.R. Vitamin A metabolism new perspectives on absorption, transport, and storage . Physiol Rev. 71:1991;951.
175. Fex G., Felding P. Factors affecting the concentration of free holo retinol-binding protein in human plasma. Eur J Clin Invest. 14:1984;146.
176. Noy N., Blaner W.S. Interactions of retinol with binding proteins studies with rat cellular retinol-binding protein and with rat retinol-binding protein . Biochemistry. 30:1991;6380.
177. Vahlquist A., Peterson P.A., Wibell L. Metabolism of the vitamin A transporting protein complex. I. Turnover studies in normal persons and in patients with chronic renal failure. Eur J Clin Invest. 3:1973;352.
178. Green M.H., Green J.B., Lewis K.C. Model-based compartmental analysis of retinol kinetics in organs of rats at different levels of vitamin A status. Livrea M.A., Packer L. Retinoids progress in research and clinical applications . 1993;185 Marcel Dekker, New York.
179. Stephensen C.B., Alvarez J.O., Kohatsu J., et al. Vitamin A is excreted in the urine during acute infection. Am J Clin Nutr. 60:1994;388.
180. Heller J. Interactions of plasma retinol-binding protein with its receptor. Specific binding of bovine and human retinol-binding protein to pigment epithelium cells from bovine eyes. J Biol Chem. 250:1975;3613.
181. Senoo H., Stang E., Nilsson A., et al. Internalization of retinol-binding protein in parenchymal and stellate cells of rat liver. J Lipid Res. 31:1990;1229.
182. van Bennekum A.M., Blaner W.S., Seifert-Bock I., et al. Retinol uptake from retinol-binding protein (RBP) by liver parenchymal cells in vitro does not specifically depend on its binding to RBP. Biochemistry. 32:1993;1727.
183. Creek K.E., St Hilaire P., Hodam J.R. A comparison of the uptake, metabolism and biologic effects of retinol delivered to human keratinocytes either free or bound to serum retinol-binding protein. J Nutr. 123:(suppl 2):1993;356.
184. Trechsel U., Evêquoz V., Fleisch H. Stimulation of interleukin 1 and 3 production by retinoic acid in vitro. Biochem J. 230:1985;339.
185. Sidell N., Ramsdell F. Retinoic acid upregulates interleukin-2 receptors on activated human thymocytes. Cell Immunol. 115:1988;299.
186. Ludwig K.W., Lowey B., Niles R.M. Retinoic acid increases cyclic AMP-dependent protein kinase activity in murine melanoma cells. J Biol Chem. 255:1980;5999.
187. Pailler-Rodde I., Garcin H., Higueret P. Effects of retinoids on protein kinase C activity and on the binding characteristics of the tri-iodothyronine nuclear receptor. J Endocrinol. 128:1991;245.
188. Zhou H., Manji S.S., Findlay D.M., et al. Novel action of retinoid acid stabilization of newly synthesized alkaline phosphatase transcripts . J Biol Chem. 269:1994;22433.
189. Connor M.J., Lowe N.J. Induction of ornithine decarboxylase activity and DNA synthesis in hairless mouse epidermis by retinoids. Cancer Res. 43:1983;5174.
190. Rajan N., Blaner W.S., Soprano D.R., Suhara A., Goodman D.S. Cellular retinol-binding protein messenger mRNA levels in normal and retinoid-deficient rats. J Lipid Res. 31:1990;821.
191. Jetten A.M. Effects of retinoic acid on the binding and mitogenic activity of epidermal growth factor. J Cell Physiol. 110:1982;235.
192. Choi Y., Fuchs E. TGF-beta and retinoic acid regulators of growth and modifiers of differentiation in human epidermal cells . Cell Regulat. 1:1990;791.
193. Kirven M.J., Wolf G. Synthesis and glycosylation of fibronectin in hepatocytes of vitamin A-deficient rats. Mol Cell Biochem. 101:1991;101.
194. Barber E.F., Cousins R.J. Induction of ceruloplasmin synthesis by retinoid acid in rats influence of dietary copper and vitamin A status . J Nutr. 117:1987;1615.
195. Kiorpes T.C., Wolf G., Arroyave G., Wai T.N.K. α2-macroglobulin in vitamin A-deficient children. Am J Clin Nutr. 32:1979;1842.
196. Chun T.Y., Carman J.A., Hayes C.E. Retinoid repletion of vitamin A-deficient mice restores IgG responses. J Nutr. 122:1992;1062.
197. Israel H., Odziemiec C., Ballow M. The effects of retinoic acid on immunoglobin synthesis by human cord blood mononuclear cells. Clin Immunol Immunopathol. 59:1991;417.
198. Dennert G., Lotan R. Effects of retinoic acid on the immune system
199. Abb J., Deinhardt F. Effects of retinoic acid on the human lymphocyte response to mitogens. Exp Cell Biol. 48:1980;169.
200. Bender J.G., Stewart C.C., Van Epps D.E., Walker D.E. 13-cis-retinoic acid augments the production of macrophages in mouse bone marrow cultures stimulated with interleukin 3. Exp Hematol. 18:1990;990.
201. Varani J., Mitra R.S., Gibbs D., et al. All-trans retinoic acid stimulates growth and extracellular matrix production in growth-inhibited cultured human skin fibroblasts. J Invest Dermatol. 94:1990;717.
202. Chytil F., Ong D.E. Cellular retinoid-binding proteins. Sporn M.B., Roberts A.B., Goodman D.S. The retinoids. Vol. 2:1984;90 Academic Press, Orlando.
203. Yost R.W., Harrison E.H., Ross A.C. Esterification by rat liver microsomes of retinol bound to cellular retinol-binding protein. J Biol Chem. 263:1988;18693.
204. Blaner W.S., Hendriks H.F.J., Brouwer A., et al. Retinoids, retinoid-binding proteins, and retinyl palmitate hydrolase distributions in different types of rat liver cells. J Lipid Res. 26:1985;1241.
205. Posch K.C., Boerman M.H., Burns R.D., Napoli J.L. Holocellular retinol binding protein as a substrate for microsomal retinal synthesis. Biochemistry. 30:1991;6224.
206. Zhao D., McCaffery P., Ivins K.J., et al. Molecular identification of a major retinoic-acid-synthesizing enzyme, a retinaldehyde-specific dehydrogenase. Eur J Biochem. 240:1996;15.
207. Chambon P. The retinoid signaling pathway molecular and genetic analyses . Semin Cell Biol. 5:1994;115.
208. Giguere V. Retinoid acid receptors and cellular retinoid binding proteins complex interplay in retinoid signaling . Endocr Rev. 15:1994;61.
209. Smith W.C., Nakshatri H., Leroy P., Rees J., Chambon P. A retinoic acid response element is present in the mouse cellular retinol binding protein I (mCRBP I) promoter. EMBO J. 10:1991;2223.
210. Lotan R. Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochim Biophys Acta. 605:1980;33.
211. Carman J.A., Hayes C.E. Abnormal regulation of IFN-gamma secretion in vitamin A deficiency. J Immunol. 147:1991;1247.
212. Sidell N., Taga T., Hirano T., Kishimoto T., Saxon A. Retinoic acid-induced growth inhibition of a human myeloma cell line via down-regulation of IL-6 receptors. J Immunol. 146:1991;3809.
213. Blomhoff H.K., Smeland E.B., Erikstein G., et al. Vitamin A is a key regulator for cell growth, cytokine production, and differentiation in normal B cells. J Biol Chem. 267:1992;23988.
214. Hunt T.K. Vitamin A and wound healing. J Am Acad Dermatol. 16:1986;817.
215. Frayn K.N., Price D.A., Maycock P.F., Carroll S.M. Plasma somatomedin activity after injury in man and its relationship to other hormonal and metabolic changes. Clin Endocrinol. 20:1984;179.
216. Baxter R.C., Bryson J.M., Turtle J.R. Somatogenic receptors of rat liver regulation by insulin . Endocrinology. 107:1980;1176.
217. Dahn M.S., Lange M.P., Jacobs L.A. Insulinlike growth factor 1 production is inhibited in human sepsis. Arch Surg. 123:1988;1409.
218. Emler C.A., Schalch D.S. Nutritionally-induced changes in hepatic insulin-like growth factor I (IGF-1) gene expression in rats. Endocrinology. 120:1987;832.
219. Bolze M.S., Osborne J.M., Vecbastiks K.A., White M.E. Insulin-like growth factor binding proteins in rats respond to fasting and the protein and energy content of the re-feeding diet. J Nutr Biochem. 2:1991;623.
220. Frost V.J., Macaulay V.M., Wass J.A.H., Holly J.M.P. Proteolytic modification of insulin-like growth factor-binding proteins comparison of conditioned media from human cell lines, circulating proteases and characterized enzymes . J Endocrinol. 138:1993;545.
221. Cwyfan Hughes S.C., Cotterill A.M., Molloy A.R., et al. The induction of specific proteases for insulin-like growth factor-binding proteins following major heart surgery. J Endocrinol. 135:1992;135.
222. Davenport M.L., Isley W.L., Pucilowska J.B., et al. Insulin-like growth factor-binding protein-3 proteolysis is induced after elective surgery. J Clin Endocrinol Metab. 75:1992;590.
223. Davies S.C., Wass J.A.H., Ross R.J.M., et al. The induction of a specific protease for insulin-like growth factor-binding protein-3 in the circulation during severe illness. J Endocrinol. 130:1991;469.
224. Lee D., Park S., Yorgin P.D., et al. Alteration in insulin-like growth factor-binding proteins (IGFBPs) and IGFBP3 protease activity in serum and urine from acute and chronic renal failure. J Clin Endocrinol Metab. 79:1994;1376.
225. Binoux M., Hossenlopp P., Lassarre C., Segovia B. Degradation of IGF binding protein-3 by proteases physiological implications . Spencer E.M. Modern concepts of insulin-like growth factors. 1991;329 Elsevier, New York.
226. Bentham J., Rodriguez-Arnao A.J., Ross R.J. Acquired growth hormone resistance in patients with hypercatabolism. Horm Res. 40:1993;87.
227. Roth E., Valentini L., Semsroth M., et al. Resistance of nitrogen metabolism to growth hormone treatment in the early phase after injury of patients with multiple injuries. J Trauma. 38:1995;136.
228. Herndon D.N., Hawkins H.K., Nguyen T.T., et al. Characterization of growth hormone enhanced donor site healing in patients with large cutaneous burns. Ann Surg. 221:1995;649.
229. D'Ercole A.J., Stiles A.D., Underwood L.E. Tissue concentrations of somatomedin C further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action . Proc Natl Acad Sci USA. 81:1984;935.
230. Rechler M.M., Nissley S.P. The nature and regulation of the receptors for insulin-like growth factors. Annu Rev Physiol. 47:1985;425.
231. Ullrich A., Gray A., Tam A.W., et al. Insulin-like growth factor I receptor primary structure comparison with insulin receptor suggests structural determinants that define functional specificity . EMBO J. 5:1986;2503.
232. Jacobs S., Kull F.C. Jr, Earp H.S., et al. Somatomedin-C stimulates the phosphorylation of the beta-subunit of its own receptor. J Biol Chem. 258:1983;9581.
233. Ding H., Gao X.L., Hirschberg R., Vadgama J.V., Kopple J.D. Impaired actions of insulin-like growth factor 1 on protein synthesis and degradation in skeletal muscle of rats with chronic renal failure. Evidence for a postreceptor defect. J Clin Invest. 97:1996;1064.
234. 131I-labeled L-thyroxine in man observations of subjects with normal and decreased serum thyroxine-binding globulin . J Clin Invest. 45:1966;939.
235. Ingenbleek Y., De Visscher M., De Nayer P. Measurement of prealbumin as index of protein-calorie malnutrition. Lancet. ii:1972;106.
236. Ingenbleek Y. Thyroid function in nutritional disorders. Delange F., Fisher D.A., Malvaux P. Pediatric thyroidology. 1985;345 Karger, Basel.
237. Ingenbleek Y., De Nayer P., De Visscher M. Thyroxine-binding globulin in infant protein-calorie malnutrition. J Clin Endocrinol Metab. 39:1974;178.
238. Straus D.S., Marten N.W., Hayden J.M., Burke E.J. Protein restriction specifically decreases the abundance of serum albumin and transthyretin nuclear transcripts in rat liver. J Nutr. 124:1994;1041.
239. Ingenbleek Y., Van den Schriek H.G., De Nayer P., De Visscher M. Albumin, transferrin and the thyroxine-binding prealbumin/retinol-binding protein (TBPA-RBP) complex in assessment of malnutrition. Clin Chim Acta. 63:1975;61.
240. Waterlow J.C. Amount and role of disappearance of liver fat in malnourished infants in Jamaica. Am J Clin Nutr. 28:1975;1330.
241. Bhaskaram P., Sivakumar B. Interleukin-1 in malnutrition. Arch Dis Child. 61:1986;182.
242. Doherty J.F., Golden M.H.N., Remick D.G., Griffin G.E. Production of interleukin-6 and tumour necrosis factor-α in vitro is reduced in whole blood of severely malnourished children. Clin Sci. 86:1994;347.
243. Muñoz C., Arévalo M., López M., Schlesinger L. Impaired interleukin-1 and tumor necrosis factor production in protein-calorie malnutrition. Nutr Res. 14:1994;347.
244. Tovey M.G., Gugenheim J., Guymarho J., et al. Genes for interleukin-1, interleukin-6, and tumor necrosis factor are expressed at markedly reduced levels in the livers of patients with severe liver disease. Autoimmunity. 10:1991;297.
245. Bartalena L., Farsetti A., Flink I.L., Robbins J. Effect of interleukin-6 on the expression of thyroid hormone-binding protein genes in cultured human hepatoblastoma-derived (Hep G2) cells. Mol Endocrinol. 6:1992;935.
246. Harvey R.F. Serum-thyroxine and thyroxine-binding globulin in seriously ill patients. Lancet. i:1971;208.
247. Episkopou V., Maeda S., Nishiguchi S., et al. Disruption of the transthyretin gene results in mice with depressed levels of plasma retinol and thyroid hormone. Proc Natl Acad Sci USA. 90:1993;2375.
248. Wei S., Episkopou V., Piantedosi R., et al. Studies on the metabolism of retinol and retinol-binding protein in transthyretin-deficient mice produced by homologous recombination. J Biol Chem. 270:1995;866.
249. Bellovino D., Morimoto T., Tosetti F., Gaetani S. Retinol binding protein and transthyretin are secreted as a complex formed in the endoplasmic reticulum in HepG2 human hepatocarcinoma cells. Exp Cell Res. 222:1996;77.
250. Jennings G., Cruickshank A., Shenkin A., Wight D.G., Elia M. Effect of aseptic abscesses in protein-deficient rats on the relationship between interleukin-6 and acute-phase protein, alpha 2-macroglobulin. Clin Sci Colch. 83:1992;731.
251. Curtis G.E., McAtear C., Formela L., Walsh A., Shenkin A. The effect of nutritional status on the cytokine and acute phase protein responses to elective surgery. Cytokine. 7:1995;380.
252. Jennings G., Bourgeois C., Elia M. The magnitude of the acute phase protein response is attenuated by protein deficiency in rats. J Nutr. 122:1992;1325.
253. Wade S., Bleiberg-Daniel F., Le Moullac B., et al. Value of serum transthyretin measurements in the assessment of marginal protein-energy malnutrition in rats. J Nutr. 118:1988;1002.
254. Kiorpes T.C., Molica S.J., Wolf G. A plasma glycoprotein depressed in vitamin A deficiency in the rat α1-macroglobulin . J Nutr. 106:1976;1659.
255. Baumann H., Firestone G.L., Burgess T.L., et al. Dexamethasone regulation of α1-acid glycoprotein and other acute phase reactants in rat liver and hepatoma cells. J Biol Chem. 258:1983;563.
256. Samuels A.M., Kadival G.V., Patel B.D., Desai A.G. Adrenocorticosteroids and corticosteroid binding globulins in protein calorie malnutrition. Am J Clin Nutr. 29:1976;889.
257. Clawson G.A., Button J., Woo C.H., Liao Y.C., Smuckler E.A. In vitro release of α1-acid glycoprotein RNA sequences shows fidelity with the acute phase response in vivo. Mol Biol Rep. 11:1986;163.
258. Shiels B.R., Northemann W., Gehring M.R., Fey G.H. Modified nuclear processing of α1-acid glycoprotein RNA during inflammation. J Biol Chem. 262:1987;12826.
259. Pepys M.B., Baltz M.L. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol. 34:1983;141.
260. Macintyre S.S., Kushner I., Samols D. Secretion of C-reactive protein becomes more efficient during the course of the acute phase response. J Biol Chem. 260:1985;4169.
261. Scrimshaw NS, Taylor CE, Gordon JE. Interactions of Nutrition and Infection. WHO Monograph series No. 57, Geneva, 1968.
262. Smythe P.M., Schonland M., Brereton-Stiles G.G., et al. Thymolymphatic deficiency and depression of cell-mediated immunity in protein-calorie malnutrition. Lancet. ii:1971;939.
263. Neumann C.G., Lawlor G.J. Jr, Stiehm E.R., et al. Immunological responses in malnourished children. Am J Clin Nutr. 28:1975;89.
264. Garre M.A., Boles J.M., Youinou P.Y. Current concepts in immune derangement due to undernutrition. JPEN. 11:1987;309.
265. Schelp F.P., Thanangkul O., Supawan V., et al. Serum proteinase inhibitors and acute-phase reactants from protein-energy malnutrition children during treatment. Am J Clin Nutr. 32:1979;1415.
266. Doherty J.F., Golden M.H.N., Raynes J.G., Griffin G.E., McAdam K.P. Acute phase response is impaired in severely malnourished children. Clin Sci. 84:1993;169.
267. Dominioni L., Dionigi R., Jemos V., et al. Effects of malnutrition on the acute phase response of plasma proteins in patients undergoing total gastrectomy. Clin Nutr. 1:1983;297.
268. Cruickshank A.M., Hansell D.T., Burns H.J.G., Shenkin A. Effect of nutritional status on acute phase protein response to elective surgery. Br J Surg. 76:1989;165.
269. Miholic J., Hudec M., Müller M.M., Domanig E., Wolner E. Early prediction of deep sternal wound infection after heart operations by alpha-1 acid glycoprotein and C-reactive protein measurements. Ann Thorac Surg. 42:1986;429.
270. Carpentier Y.A., Barthel J., Bruyns J. Plasma protein concentration in nutritional assessment. Proc Nutr Soc. 41:1982;405.
271. Bernstein L., Bachman T.E., Meguid M., et al. Measurement of visceral protein status in assessing protein and energy malnutrition: standard of care. Prealbumin in nutritional care Consensus Group. Nutrition. 11:1995;169.
272. Baumann H., Gauldie J. The acute phase response. Immunol Today. 15:1994;74.